Hims vs LivBody: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher & Publisher

Reviewed & updated August 14, 2026 · Cites primary sources (FDA, NEJM, CMS) · Not medical advice

54 providers verified independently·Independent research·How we rank →

Short answer: Hims scores higher on our rubric, 7.9/10 against 2.9/10. Full reasoning, pricing and the cases where the other one wins are below.

Visit Embody - our featured pick →or find your match

Hims beats LivBody overall, scoring 7.9/10 vs 2.9/10. Published pricing is not a like-for-like monthly comparison: Hims is $188 first month, then $298/mo; LivBody is from $179/mo. Choose Hims for men who want a well-known publicly-traded brand and fda-approved wegovy through the 2026 novo nordisk partnership, but should know going in that hims' customer-experience signal is weaker than smaller competitors. Choose LivBody for followers of the livbody supplement brand who specifically want compounded glp-1 injections tied to a name they already know, and who will confirm the real monthly price at checkout before paying.

A side-by-side look at Hims and LivBody to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Higher Rated

Hims

#7 of 54

7.9/10

The household name in men's telehealth, publicly traded as Hims & Hers Health (NYSE: HIMS). In 2026 Hims added FDA-approved brand-name Wegovy, Ozempic, Foundayo, and Zepbound paths and has since exited compounded semaglutide for new retail patients. The advertised medication floor is $149, but the required Weight Loss Membership adds $39 in month one and $149/month after that, so the all-in floor is $188 initially and $298 ongoing before any product- or dose-specific increase. Its parent still reports offering access to compounded GLP-1 medications on a limited scale (Q2 2026 results, filed with the SEC August 10, 2026). Brand recognition and product breadth are real strengths. The trade-off: Hims' verified Trustpilot rating is 3.0 stars across 8,286 reviews (May 2026), significantly below smaller competitors like Henry Meds (4.5) or Eden Health (4.5). The 1-star pool is 28%, the highest 1-star rate in our table, clustered around subscription/billing complaints.

Visit Hims

LivBody

#54 of 54

2.9/10

GLP-1 telehealth program from LivBody, the fitness-influencer supplement brand founded by Paige Hathaway in 2018 (legal entity LivBody HoldCo LLC). The GLP-1 arm launched around early 2026 and is an OpenLoop white-label: clinicians come from OpenLoop Healthcare Partners, PC (the terms also use the name 'LivBody Healthcare Partners, PC'), the listed Des Moines, IA headquarters is OpenLoop's office, and cancellations go through an OpenLoop support desk. Sells compounded semaglutide and compounded tirzepatide as weekly injections, with the consult and free expedited overnight shipping included in the monthly price. Prescriptions are filled by four named compounding pharmacies: RedRock Pharmacy (UT), Health Warehouse (KY), Precision Compounding (NY), and Triad Rx (AL).

Visit LivBody

Feature	Hims	LivBody
Our Score	7.9/10	2.9/10
Headline Price	$188 first month, then $298/mo	from $179/mo
Medication Type	Brand	Compounded
Insurance Accepted	No	No
Best For	Men who want a well-known publicly-traded brand and FDA-approved Wegovy through the 2026 Novo Nordisk partnership, but should know going in that Hims' customer-experience signal is weaker than smaller competitors	Followers of the LivBody supplement brand who specifically want compounded GLP-1 injections tied to a name they already know, and who will confirm the real monthly price at checkout before paying
Watch out for	Pending federal enforcement action. On July 29, 2026 the FTC, joined by Utah and California acting through Los Angeles County Counsel, filed a complaint against Hims & Hers Health, Inc. in the U.S. District Court for the Northern District of California, alleging violations of the FTC Act and the Restore Online Shoppers' Confidence Act over subscription billing, cancellation friction, and sharing consumer health information with advertising platforms. Case status is Pending. These are allegations, not findings, and Hims has not been found liable.	Pricing contradicts itself on the SAME page: landing cards say 'Starting at $179'/mo semaglutide and $279/mo tirzepatide, but the FAQ says the program 'starts at just $249/month'. Checkout is captcha-gated, so we could not resolve which number is real, confirm the actual price at checkout before paying
Ranking	#7	#54
Get started	Visit Hims	Visit LivBody

Pros & Cons Compared

Hims

Pros

+Publicly traded company (NYSE: HIMS), SEC-filed financials, regulatory accountability that private competitors don't have.
+2026 Novo Nordisk partnership, FDA-approved Wegovy injection, Wegovy pill, and Ozempic now available directly through Hims. Real brand-name access from a single platform.
+Medication starts at $149/mo for Wegovy pill, Foundayo, and Ozempic pill; Wegovy or Ozempic pens start at $199 and Zepbound at $299. The required membership makes the lowest all-in path $188 in month one and $298/mo ongoing, and exact product or dose can cost more.
+Polished app and web experience, among the best user interfaces in men's telehealth.
+8,286 verified Trustpilot reviews is the second-largest review volume in our table (after Henry's 12,461), significant real-world adoption.

Cons

−Pending federal enforcement action. On July 29, 2026 the FTC, joined by Utah and California acting through Los Angeles County Counsel, filed a complaint against Hims & Hers Health, Inc. in the U.S. District Court for the Northern District of California, alleging violations of the FTC Act and the Restore Online Shoppers' Confidence Act over subscription billing, cancellation friction, and sharing consumer health information with advertising platforms. Case status is Pending. These are allegations, not findings, and Hims has not been found liable.
−Trustpilot rating is 3.0 stars / 8,286 reviews (May 2026), significantly below Henry Meds (4.5), Eden Health (4.5), Yucca Health (4.6), MEDVi (4.4). The lowest customer-experience signal of any major brand we track.
−28% of Trustpilot reviews are 1-star, the highest 1-star rate in our table. Top complaint themes: subscription handling, unexpected charges, customer service responsiveness.
−Hims reviews span ALL their products (ED, hair loss, mental health, weight loss), not just GLP-1. But the rating still applies because most users don't separate experiences by product.
−'Hims Oral Kit' is NOT a GLP-1, it's a non-GLP-1 metabolic combination (metformin + bupropion + topiramate + B12 + naltrexone). Do not confuse its $69 price with the current brand-name GLP-1 menu.
−The $149 GLP-1 figures are medication-only. A required Weight Loss Membership costs $39 in month one and $149/mo ongoing, so a $149 medication path totals at least $188 initially and $298/mo after that.
−Cash-pay only, Hims does not bill insurance, so an insured buyer may do better on a copay.
−Generic high-volume support, large patient base means less personalized attention than smaller competitors.

LivBody

Pros

+Four compounding pharmacies named WITH street addresses, RedRock Pharmacy (UT), Health Warehouse (KY), Precision Compounding (NY), and Triad Rx (AL), more pharmacy transparency than most competitors offer
+Named medical group, OpenLoop Healthcare Partners, PC, most white-label storefronts name no one
+Consult and shipping included in the monthly price ('no hidden fees'), with free expedited overnight shipping
+Real 8-year-old brand with a named founder, Paige Hathaway founded LivBody in 2018, this is not an anonymous pop-up storefront
+Proper compounded-medication disclosures, the site states plainly that compounded GLP-1s are not FDA-approved
+Available in all 50 states plus DC (terms hedge that 'some services may not be available in all states')

Cons

−Pricing contradicts itself on the SAME page: landing cards say 'Starting at $179'/mo semaglutide and $279/mo tirzepatide, but the FAQ says the program 'starts at just $249/month'. Checkout is captcha-gated, so we could not resolve which number is real, confirm the actual price at checkout before paying
−Terms state ALL FEES NON-REFUNDABLE (in all-caps), which contradicts an undefined 'LIV Body guarantee' badge on the landing page
−The GLP-1 program is an OpenLoop white-label: clinicians are OpenLoop Healthcare Partners, PC, the listed Des Moines HQ is OpenLoop's office, and the cancellation desk is an OpenLoop zohodesk email. The LivBody supplement brand is not the one treating you
−Zero independent GLP-1 track record: Trustpilot shows 0 reviews (profile claimed February 2026), and the BBB rates the supplement entity (Liv Body LLC, Henderson NV) B-, not accredited, with an unanswered complaint
−Supplement-product testimonials are recycled onto the GLP-1 page as patient social proof
−Pharmacy partner Triad Rx (AL) received a 2019 FDA warning letter for sterile-production violations; the FDA closed it out in May 2023, we state both facts because both matter
−Broken legal links: the Medical Consent and Patient Bill of Rights documents point to start.livbody.com, a domain that does not resolve
−No named medical director, no labs, no video-visit path, no clinical infrastructure disclosed beyond the OpenLoop group name
−Injectables only, no oral or sublingual option, no microdose tier, no brand-name access, and no LegitScript certification found (the site links only the LegitScript checker)

Our Verdict

Hims edges out LivBody with a score of 7.9/10 vs 2.9/10. Published pricing is not a like-for-like monthly comparison: Hims is $188 first month, then $298/mo; LivBody is from $179/mo.